Opinions

Fabrice Taylor IMRIS Inc. IM-T HOLD Jan 28, 2015

Manufactures surgical suite equipment. Did a financing and the insiders took the entire financing just before Christmas. Has never seen insiders take an entire financing and lose money. Because of this, he thinks it can go higher. Expect they are going to have a good year.

Fabrice Taylor

Owned

Unlock Rating

$0.990

Stock price when the opinion was issued

other services

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Medical imaging company. Cross between health care and technology. They sold about 40 of their MRI units, which can be wheeled into surgery. Great management team. Strong investment in the company – management owns 30%. Just starting to hit profitability.

BUY

(Market Call Minute) Portable MRI equipment for hospitals. Longer term play.

DON'T BUY

A technology company that uses a robot to dramatically improve the odds in surgery. Hasn’t had significant traction as of yet. Very interesting technology, but near-term estimates of earnings don’t show a lot of joy for the company.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Fabrice Taylor IMRIS Inc. IM-T HOLD Jan 28, 2015

You might be interested:

IMRIS Inc.(IM-T)

IMRIS Inc.(IM-T)

IMRIS Inc.(IM-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Brendan Caldwell

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase Insights

Jim Cramer - Mad Money